OptiBiotix Health Plc (AIM:OPTI)

London · Delayed Price · Currency is GBP · Price in GBX

5.61

+0.01 (0.20%)

Jul 24, 2026, 3:30 PM GMT

-50.12% (1Y)

Market Cap	5.78M -50.2%
Revenue (ttm)	1.17M +34.0%
Net Income	-3.89M
EPS	-0.04
Shares Out	103.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	191,632
Open	5.61
Previous Close	5.60
Day's Range	5.58 - 5.61
52-Week Range	4.50 - 13.50
Beta	1.85
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 16, 2026

About OptiBiotix Health

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its first-generation products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunge... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2006

Employees 9

Stock Exchange London Stock Exchange AIM

Ticker Symbol OPTI

Full Company Profile

Financial Performance

In 2025, OptiBiotix Health's revenue was 1.17 million, an increase of 34.02% compared to the previous year's 870,000. Losses were -3.89 million, 115.5% more than in 2024.

Financial Statements